Hostname: page-component-848d4c4894-jbqgn Total loading time: 0 Render date: 2024-07-03T07:18:02.224Z Has data issue: false hasContentIssue false
  • English
  • Français

Cyclamin, a new Molluscicide from the tubers of Cyclamenpurpurascens Mill. tested against the snail Biomphalaria glabrata (Say)

Published online by Cambridge University Press:  01 February 2009

O. Winder ,
C. Friedrich ,
N. D. Jumbam ,
H. Griengl  and
T. Kartnig
O. Winder
Affiliation:
Institut für Organische Chemie der Technischen Universität Graz, Stremayrgasse 16, A-8010 Graz, Austria
C. Friedrich
Affiliation:
Institut für Organische Chemie der Technischen Universität Graz, Stremayrgasse 16, A-8010 Graz, Austria
N. D. Jumbam
Affiliation:
Institut für Organische Chemie der Technischen Universität Graz, Stremayrgasse 16, A-8010 Graz, Austria
H. Griengl
Affiliation:
Institut für Organische Chemie der Technischen Universität Graz, Stremayrgasse 16, A-8010 Graz, Austria
T. Kartnig
Affiliation:
Institut für Pharmakognosie der Karl-Franzens-Universität Graz, Universitätsplatz 4, A-8010 Graz, Austria
Get access

Abstract

Cyclamin, a monodesmosidic triterpenoid saponin isolated from the tubers of Cyclamen purpurascens Mill. was found to possess molluscicidal activity against the schistosomiasis-transmitting snail Biomphalaria glabrata (Say). The lowest concentration showing 100 % mortality to snails was 21 mg/l. The haemolytic activity and the molluscicidal potency of cyclamin were compared with those of primulic acid with the result that high haemolytic activity will not automatically imply a strong molluscicidal potency.

Keywords

biomphalaria glabratacyclamen purpurascenscyclaminmolluscicidesaponinschistosomiasisbiomphalaria glabratacyclamen purpurascenscyclaminemollusquicidesaponineschistosomiase
Type
Research Article
Information
Annales de Limnologie - International Journal of Limnology , Volume 31 , Issue 4 , December 1995 , pp. 229 - 232
Copyright
© Gauthier-Villars, 1995

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)